The consistent expression of CD74 on normal and transformed B cells, its rapid internalization, as well as growth-inhibitory and death-inducing effects in vitro on B cell non-Hodgkin lymphoma (B-NHL) cells, brought CD74 into focus as a therapeutic target [39]. This evidence concerns the gene CD74 and B-cell non-Hodgkin lymphoma.